• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

奥希替尼诱发的Takotsubo心肌病复发：一例报告

Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report.

作者信息

Fukuda Yuko, Kawa Yoshitaka, Nonaka Akiko, Shiotani Hideyuki

机构信息

Division of Onco-cardiology Hyogo cancer center Akashi Japan.

Division of Respiratory Medicine Hyogo cancer center Akashi Japan.

出版信息

Clin Case Rep. 2022 Sep 2;10(9):e6279. doi: 10.1002/ccr3.6279. eCollection 2022 Sep.

DOI:10.1002/ccr3.6279
PMID:36093451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9440339/
Abstract

A patient with lung cancer was administrated osimertinib. She developed symptomatic heart failure due to Takotsubo cardiomyopathy (TC). As her condition improved after discontinuing osimertinib, TC was thought to be caused by osimertinib. Reoccurrence of TC was seen after readministrating half dose of osimertinib.

摘要

一名肺癌患者接受了奥希替尼治疗。她因应激性心肌病（TC）出现了有症状的心力衰竭。由于停用奥希替尼后她的病情有所改善，所以认为TC是由奥希替尼引起的。再次给予半剂量奥希替尼后，出现了TC复发。

相似文献

1
Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report.奥希替尼诱发的Takotsubo心肌病复发：一例报告
Clin Case Rep. 2022 Sep 2;10(9):e6279. doi: 10.1002/ccr3.6279. eCollection 2022 Sep.
2
Osimertinib induced cardiomyopathy: A case report.奥希替尼诱发的心肌病：一例报告。
Medicine (Baltimore). 2020 Sep 25;99(39):e22301. doi: 10.1097/MD.0000000000022301.
3
A case of reverse takotsubo cardiomyopathy caused by an eating disorder.一例由饮食失调引起的反向应激性心肌病病例。
J Cardiol Cases. 2016 Nov 24;15(3):77-79. doi: 10.1016/j.jccase.2016.10.015. eCollection 2017 Mar.
4
A case report of recurrent takotsubo cardiomyopathy including the rare 'inverted' form.一例复发性应激性心肌病的病例报告，包括罕见的“倒置”型。
Eur Heart J Case Rep. 2022 May 20;6(6):ytac207. doi: 10.1093/ehjcr/ytac207. eCollection 2022 Jun.
5
Zumba-induced Takotsubo cardiomyopathy: a case report.尊巴引发的应激性心肌病：一例报告
J Med Case Rep. 2018 Jun 10;12(1):160. doi: 10.1186/s13256-018-1696-x.
6
Takotsubo cardiomyopathy following pacemaker insertion complicated with polymorphic ventricular tachycardia: a case report.起搏器植入术后并发Takotsubo 心肌病伴多形性室性心动过速 1 例报告。
J Med Case Rep. 2024 May 6;18(1):238. doi: 10.1186/s13256-024-04565-5.
7
Takotsubo cardiomyopathy induced by suicidal neck hanging.自杀性缢颈所致的应激性心肌病
J Emerg Med. 2015 Feb;48(2):e35-8. doi: 10.1016/j.jemermed.2014.10.003. Epub 2014 Nov 20.
8
Heart Failure With Reduced Ejection Fraction Caused by Osimertinib in a Patient With Lung Cancer: A Case Report and Literature Review.奥希替尼导致肺癌患者射血分数降低的心力衰竭：一例报告及文献综述
Cureus. 2022 Aug 5;14(8):e27694. doi: 10.7759/cureus.27694. eCollection 2022 Aug.
9
Takotsubo cardiomyopathy complicated by cardiac tamponade due to non-hemorrhagic pericardial effusion: a case report.因非出血性心包积液并发心脏压塞的 Takotsubo 心肌病：一例报告。
BMC Cardiovasc Disord. 2020 Feb 6;20(1):67. doi: 10.1186/s12872-020-01377-5.
10
Can Breaking Heroin Addiction Lead to a Broken Heart? A Case of Reverse Takotsubo Cardiomyopathy in a Patient With Heroin Withdrawal.戒毒会导致心碎吗？一例海洛因戒断患者的逆性 Takotsubo 心肌病。
Tex Heart Inst J. 2023 Mar 1;50(2). doi: 10.14503/THIJ-21-7604.

引用本文的文献

1
Real-World Data on Osimertinib-Associated Cardiac Toxicity.奥希替尼相关心脏毒性的真实世界数据。
J Clin Med. 2025 Mar 5;14(5):1754. doi: 10.3390/jcm14051754.
2
SGLT2 Inhibitor for Cardiac Protection in a Patient With Osimertinib-Responsive Advanced EGFR-Positive Lung Cancer.SGLT2抑制剂对奥希替尼敏感的晚期EGFR阳性肺癌患者的心脏保护作用
JACC Case Rep. 2024 Dec 4;29(23):102829. doi: 10.1016/j.jaccas.2024.102829.
3
EGFR-TKIs - induced cardiotoxicity in NSCLC: incidence, evaluation, and monitoring.表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKIs）诱导的非小细胞肺癌心脏毒性：发生率、评估及监测

本文引用的文献

1
Cardiac Adverse Events in -Mutated Non-Small Cell Lung Cancer Treated With Osimertinib.奥希替尼治疗携带EGFR突变的非小细胞肺癌患者的心脏不良事件
JACC CardioOncol. 2020 Mar 17;2(1):1-10. doi: 10.1016/j.jaccao.2020.02.003. eCollection 2020 Mar.
2
Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS).奥希替尼所致心脏毒性：对美国食品药品监督管理局不良事件报告系统（FAERS）的回顾性分析
JACC CardioOncol. 2019 Dec 17;1(2):172-178. doi: 10.1016/j.jaccao.2019.10.006. eCollection 2019 Dec.
3
Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction.
Front Oncol. 2024 Jun 24;14:1426796. doi: 10.3389/fonc.2024.1426796. eCollection 2024.
4
Onset of takotsubo syndrome induced by osimertinib in a patient with lung adenocarcinoma.奥希替尼诱发肺腺癌患者发生Takotsubo综合征
Respir Med Case Rep. 2024 May 31;50:102056. doi: 10.1016/j.rmcr.2024.102056. eCollection 2024.
5
Osimertinib-Associated Cardiomyopathy In Patients With Non-Small Cell Lung Cancer: A Case Series.奥希替尼相关的非小细胞肺癌患者心肌病：病例系列
JACC CardioOncol. 2023 Oct 3;5(6):839-841. doi: 10.1016/j.jaccao.2023.07.006. eCollection 2023 Dec.
奥希替尼与可逆的、剂量无关的癌症治疗相关心脏功能障碍有关。
Lung Cancer. 2021 Mar;153:186-192. doi: 10.1016/j.lungcan.2020.10.021. Epub 2020 Nov 16.
4
Osimertinib for Japanese patients with T790M-positive advanced non-small-cell lung cancer: A pooled subgroup analysis.奥希替尼治疗 T790M 阳性晚期非小细胞肺癌日本患者：一项汇总亚组分析。
Cancer Sci. 2019 Sep;110(9):2884-2893. doi: 10.1111/cas.14120. Epub 2019 Aug 1.
5
Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review.应激性心肌病的诊断与治疗：美国心脏病学会心血管造影及介入治疗学会最新临床观点。
J Am Coll Cardiol. 2018 Oct 16;72(16):1955-1971. doi: 10.1016/j.jacc.2018.07.072.
6
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy.Takotsubo（应激性）心肌病的临床特征和转归。
N Engl J Med. 2015 Sep 3;373(10):929-38. doi: 10.1056/NEJMoa1406761.
7
Chemotherapy-induced takotsubo cardiomyopathy.化疗诱导的心肌扩张型心肌病。
Heart Fail Clin. 2013 Apr;9(2):233-42, x. doi: 10.1016/j.hfc.2012.12.009. Epub 2013 Jan 23.
8
ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease.表皮生长因子受体（ErbB）1-4 依赖性表皮生长因子（EGF）/神经调节素信号及其在中枢神经系统中的相互作用：精神分裂症和帕金森病中的病理意义。
Front Cell Neurosci. 2013 Feb 13;7:4. doi: 10.3389/fncel.2013.00004. eCollection 2013.
9
Cardiotoxicity induced by tyrosine kinase inhibitors.酪氨酸激酶抑制剂所致心脏毒性。
Acta Oncol. 2009;48(7):964-70. doi: 10.1080/02841860903229124.
10
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition.酪氨酸激酶抑制导致心脏毒性的分子机制。
Nat Rev Cancer. 2007 May;7(5):332-44. doi: 10.1038/nrc2106.